1. Home
  2. BIVI vs MSS Comparison

BIVI vs MSS Comparison

Compare BIVI & MSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIVI
  • MSS
  • Stock Information
  • Founded
  • BIVI 2013
  • MSS 2019
  • Country
  • BIVI United States
  • MSS United States
  • Employees
  • BIVI N/A
  • MSS N/A
  • Industry
  • BIVI Biotechnology: Pharmaceutical Preparations
  • MSS
  • Sector
  • BIVI Health Care
  • MSS
  • Exchange
  • BIVI Nasdaq
  • MSS Nasdaq
  • Market Cap
  • BIVI 18.6M
  • MSS 18.1M
  • IPO Year
  • BIVI N/A
  • MSS 2023
  • Fundamental
  • Price
  • BIVI $0.97
  • MSS $0.92
  • Analyst Decision
  • BIVI
  • MSS
  • Analyst Count
  • BIVI 0
  • MSS 0
  • Target Price
  • BIVI N/A
  • MSS N/A
  • AVG Volume (30 Days)
  • BIVI 210.2K
  • MSS 84.2K
  • Earning Date
  • BIVI 05-12-2025
  • MSS 08-12-2025
  • Dividend Yield
  • BIVI N/A
  • MSS N/A
  • EPS Growth
  • BIVI N/A
  • MSS N/A
  • EPS
  • BIVI N/A
  • MSS N/A
  • Revenue
  • BIVI N/A
  • MSS $111,744,690.00
  • Revenue This Year
  • BIVI N/A
  • MSS N/A
  • Revenue Next Year
  • BIVI N/A
  • MSS N/A
  • P/E Ratio
  • BIVI N/A
  • MSS N/A
  • Revenue Growth
  • BIVI N/A
  • MSS 102.07
  • 52 Week Low
  • BIVI $0.62
  • MSS $0.60
  • 52 Week High
  • BIVI $7.50
  • MSS $2.08
  • Technical
  • Relative Strength Index (RSI)
  • BIVI 42.25
  • MSS 49.43
  • Support Level
  • BIVI $0.88
  • MSS $0.88
  • Resistance Level
  • BIVI $1.03
  • MSS $0.95
  • Average True Range (ATR)
  • BIVI 0.07
  • MSS 0.05
  • MACD
  • BIVI -0.02
  • MSS 0.00
  • Stochastic Oscillator
  • BIVI 23.97
  • MSS 55.87

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About MSS Maison Solutions Inc.

Maison Solutions Inc is a fast-growing, specialty grocery retailer offering traditional Asian food and merchandise to modern U.S. consumers, particularly members of Asian-American communities. It is committed to providing Asian fresh produce, meat, seafood, and other daily necessities in a manner that caters to traditional Asian-American family values and cultural norms, while also accounting for the new and faster-paced lifestyle of younger generations and the diverse communities in which it operates. The company's merchandise includes fresh and, meats, seafood, and other groceries that are not found in mainstream supermarkets, including a variety of Asian vegetables and fruits such as broccoli, bitter melon, winter gourd, Shanghai baby bok choy, longan, and lychee.

Share on Social Networks: